Navigation Links
New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging

or at least three years (mean 19.8 years) with a man aged 35 to 65 (mean age 48.8 years) was conducted by Harris Interactive on behalf of Spirit of Women, a national coalition that inspires health and wellness for women and their families on a local level by leveraging national resources.

Scientific research links decreased levels of testosterone in men to a number of significant medical conditions, including metabolic syndrome, insulin resistance, Type 2 diabetes, abnormal blood lipids, cardiovascular disease and osteoporosis.(2) The most recent research, conducted by the University of California at San Diego, found low testosterone may lead to a greater risk of death in men aged 50 and older. The study tracked nearly 800 men, 50 to 91 years old, living in California and found that men with low testosterone had a 33 percent greater death risk over their next 18 years of life compared with men who had higher testosterone.

    Other Key Survey Findings

    The survey also found:

    -- Among women with symptomatic partners, 44% of those whose partners have

       not visited his doctor predict that the barrier to visiting is that he

       thinks his symptoms are a normal part of aging.

    -- Among women with symptomatic partners, 18% have not discussed their

       partner's symptoms and 28% report that they are not comfortable

       discussing his symptoms.


    The Symptoms of Low T Negatively Affect Relationship Quality

    -- Women with symptomatic (27%) or diagnosed (48%) partners indicate that

       the symptoms of low T affect/ affected their relationship.

    -- Less physical intimacy is mentioned by women with symptomatic partners

       (72%) and women with diagnosed partners (78%) as the largest impact

       symptoms have or had on their relationship.

    -- Women with symptomatic partners also report that communication with

       their partner suffers (51%) and that they feel more lonely (47%).

    -- Two-thirds of w
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
Post Your Comments:
(Date:11/18/2014)... , Nov. 17, 2014   Headquartered ... Inc. (OTC: GWPC) is a diversified company.  WholeHEALTH ... convenience of advanced technology and proven expertise of ... business of health and wellness.  WholeHEALTH Products, comprehensive ... doctors, clinics and healthcare centers, and 8 retail ...
(Date:11/18/2014)... , Nov. 18, 2014  Cardica, Inc. (Nasdaq: ... Cardica Board has approved management,s recommendation to shift ... of the MicroCutter XCHANGE® 30 surgical stapler to ... launch.  As a result, Cardica has temporarily suspended ... its latest iteration of the MicroCutter XCHANGE 30 ...
(Date:11/18/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... the receipt of approval from the U.S. Food and ... IDEAL IMPLANT ® Saline-filled Breast Implant ... existing augmentation implants. The FDA approval of the IDEAL ... studies and data including a U.S. clinical trial that ...
Breaking Medicine Technology:WholeHEALTH Product Inc. to File FDA Emergency Use Approval (EUA) for PCR Rapid Ebola Test 2Cardica Announces Shift In Focus 2Cardica Announces Shift In Focus 3Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 2Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 3
... 29, 2011 As small businesses struggle to afford ... concern that forthcoming Essential Health Benefits regulations could include ... to raise prescription drug costs, the Pharmaceutical Care ... (PBMs) administer drug benefits for thousands of small businesses ...
... JOLLA, Calif., Sept. 29, 2011 Synthetic Genomics Vaccines, ... next generation vaccines using genomic sequencing and synthetic genomic ... been appointed as president.  Dr. Farah brings extensive vaccine ... executive management experience in the biotechnology industry to SGVI. ...
Cached Medicine Technology:Some Essential Benefits Rules Could Worry Small Businesses 2Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President 2
(Date:11/18/2014)... TX (PRWEB) November 18, 2014 ... advice and insights, adding to the company's reputation ... Explore everything the blog has to offer at ... through all the information concerning the Affordable Care ... blog aims to inform the public about a ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... An experimental antibody drug could prove effective at lowering ... effects with cholesterol-lowering statin medications. That,s the conclusion ... Heart Association annual meeting in Chicago. The drug, ... most widely used alternative to statins, Zetia, said lead ...
(Date:11/18/2014)... Women who started smoking at a young age may ... a new study suggests. About 29 percent of ... suspected as a risk factor for severe menstrual pain, ... new study said. The researchers analyzed data from ... women,s health in Australia. About 14 percent of the ...
(Date:11/18/2014)... GA (PRWEB) November 18, 2014 ... focused on using the telehealth platform to bring ... Because of this passion, GPT created Global Partnership ... utilizing GPT’s already existing telehealth network. GPTM ... orphanages, hospitals overseas, and disaster relief organizations. ...
(Date:11/18/2014)... (PRWEB) November 18, 2014 Sometimes at ... situations with print devices like unforeseen error messages or ... don't have time to find another printer and they ... The IT department is likely tied up with other ... , That’s where Electronic Systems, Inc. (ESI) ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Building Virtual Library of Resources to Help Consumers Navigate Healthcare Landscape 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2Health News:Electronic Systems, providing Managed Print Services (MPS) in Virginia & Outer Banks North Carolina 2
... Researchers at the University of Florida and Metagenics Inc. today ... combined with a low-glycemic, Mediterranean-style diet is almost twice as ... risk factors for cardiovascular disease, the leading cause of death ... medical food UltraMeal PLUS 360 is 40 percent more likely ...
... May 19 (HealthDay News) -- Summer fun can take a ... a common infection that accounts for almost $500 million in ... report. Swimmer,s ear results in 2.4 million doctor ... average of $200, according to the report from the U.S. ...
... FL (May 19, 2011)Researchers from the University of Miami (UM) ... different teaching models for children with Autism Spectrum Disorder (ASD). ... the fidelity of treatment models for preschoolers with autism. ... the journal Research in Autism Spectrum Disorders . ...
... ARBOR, Mich. A primary reason that head and neck ... chemotherapy drugs. Now, researchers at the University of Michigan Comprehensive ... Indian spice curcumin can help cells overcome that resistance. ... head and neck cancer cell lines, they were able to ...
... have been diagnosed with poor sperm quality and who are ... Researchers have found that while cell phone use appears to ... may also lead to low sperm quality and a decrease ... puzzling," says Rany Shamloul, a postdoctoral fellow in the Department ...
... Crohn,s patients in a research study at Penn ... a chronic inflammatory condition of the gastrointestinal tract ... loss. Treatments for Crohn,s disease are designed to ... rare but serious side effects, including infections and ...
Cached Medicine News:Health News:Breakthrough medical food reverses risk of heart disease and diabetes 2Health News:Breakthrough medical food reverses risk of heart disease and diabetes 3Health News:Swimmer's Ear Costs Up to $500 Million a Year in U.S. 2Health News:Validating preschool programs for children with autism 2Health News:Curcumin compound improves effectiveness of head and neck cancer treatment, U-M study finds 2Health News:Use of naltrexone reduces inflammation in Crohn's patients 2
Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption....
Lyphochek Maternal Serum Control is a trilevel product with analytes at clinically significant levels to monitor maternal serum analysis....
... Immunoassay Plus Control is a ... in today's busy immunoassay laboratory. ... this human serum based control ... separate control products for immunoassay ...
... The Vidiera NsD Nucleic Sample Detection ... acids, post amplification. The new platform ... by capillary electrophoresis (CE), with software features ... and flexibility. Vidiera NsD has the ...
Medicine Products: